---
title: "688331.SH (688331.SH) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/688331.SH/news.md"
symbol: "688331.SH"
name: "688331.SH"
parent: "https://longbridge.com/zh-HK/quote/688331.SH.md"
datetime: "2026-03-11T12:50:38.896Z"
locales:
  - [en](https://longbridge.com/en/quote/688331.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688331.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688331.SH/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/688331.SH/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/688331.SH/news.md)


# 688331.SH (688331.SH) — 相關新聞

### [](https://longbridge.com/zh-HK/news/278483822.md)
*2026-03-10T03:15:17.000Z*
> The A-share innovative drug concept continues to strengthen, with Salubris hitting the daily limit, HITECK and WECOME ri

### [Future Health Industry Weekly Report (02.27 - 03.06): Pharmaceutical Industry Dynamics](https://longbridge.com/zh-HK/news/278189047.md)
*2026-03-07T02:09:16.000Z*
> This week's pharmaceutical industry updates include: Jet Bio-Filtration acquired 70% equity of Jieke Membrane for 7.9198

### [A Look At RemeGen’s Valuation After Its Strong Full Year Profit Turnaround](https://longbridge.com/zh-HK/news/278133936.md)
*2026-03-06T15:52:23.000Z*
> RemeGen (SEHK:9995) has reported a significant turnaround, moving from a net loss to a net profit for the full year 2025

### [Innovative drugs see a collective surge again](https://longbridge.com/zh-HK/news/278126802.md)
*2026-03-06T08:25:08.000Z*
> On March 6th, the innovative drug sector performed strongly, with companies such as Asieris and RemeGen seeing significa

### [The Hang Seng Index closed up 1.72%, with the innovative drug sector leading the gains](https://longbridge.com/zh-HK/news/278052464.md)
*2026-03-06T08:12:18.000Z*
> The Hang Seng Index closed up 1.72%, and the Hang Seng Tech Index rose 3.15%. JD LOGISTICS rose over 20%, RemeGen rose o

### [The three major A-share indices collectively rose during the midday break, with agricultural stocks leading the gains](https://longbridge.com/zh-HK/news/278022150.md)
*2026-03-06T03:34:57.000Z*
> 36Kr learned that the three major A-share indices collectively rose during the midday break, with the Shanghai Composite

### [Understanding the Market | RemeGen rises over 6%, with a 2025 shareholder profit of 709 million yuan; institutions expect its cash reserves to increase significantly](https://longbridge.com/zh-HK/news/278016108.md)
*2026-03-06T02:24:04.000Z*
> RemeGen's stock price rose over 6%, with an increase of 6.44% as of the time of writing, reported at HKD 81.75, with a t

### [<After-hours Hong Kong Stock Market> The Hang Seng Index closed up 0.28%, the Tech Index fell 0.69%, and power equipment stocks surged](https://longbridge.com/zh-HK/news/277904425.md)
*2026-03-05T08:38:09.000Z*
> The Hong Kong stock market showed mixed performance on Thursday, with the Hang Seng Index rising by 0.28% and the Hang S

### [Nomura raises the target price of RemeGen to 79.64 yuan, maintaining a "Neutral" rating as financial conditions improve](https://longbridge.com/zh-HK/news/277866367.md)
*2026-03-05T02:21:42.000Z*
> Nomura raised the target price for RemeGen to RMB 79.64, maintaining a "Neutral" rating. The report predicts that RemeGe

### [RemeGen Returns to Profit in 2025; Shares Down 6%](https://longbridge.com/zh-HK/news/277405090.md)
*2026-03-02T04:51:35.000Z*
> RemeGen Returns to Profit in 2025; Shares Down 6%